OPKO Health (NASDAQ:OPK) executives said the company exited 2025 with “tremendous momentum,” citing efforts to reposition its ...
NEW YORK, NY, UNITED STATES, January 30, 2026 /EINPresswire.com/ — Creative Bioarray, one of the leading providers of innovative biological research tools and ...
SARANAC LAKE, N.Y., Jan. 28, 2026 /PRNewswire/ -- Bionique Testing Laboratories (Bionique), a subsidiary of Asahi Kasei and a globally recognized specialist in mycoplasma and biosafety testing ...
Meta plans to test new subscriptions that give people access to exclusive features on its apps, the company told TechCrunch on Monday. The tech giant said the new subscriptions will unlock more ...
OpenAI said Friday that it would start rolling out ads in ChatGPT to some U.S. users, as the company aims to generate more revenue ahead of a highly anticipated initial public offering. The company ...
Researchers have presented a new method for measuring how effectively antibiotics kill bacteria. Antibiotic-resistant bacteria are one of the biggest health problems of our time. Due to mutations, ...
Shanx Medtech BV raised €15 million (US$17.5 million) in a seed funding round for its in vitro diagnostic platform for ultra-rapid antimicrobial susceptibility testing. The financing came from a range ...
Hosted on MSN
YD Bio provides update on OkaiDx testing portfolio
YD Bio (YDES)provided an update to its November 5, 2025 announcement regarding U.S. access to the OkaiDx platform for post-treatment breast cancer monitoring, detailing the continued expansion of ...
What we know so far: A Moscow neurotechnology company with close ties to Russia's state innovation ecosystem is testing a system that turns ordinary pigeons into remotely guided "biodrones" using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results